Stocks
GlaxoSmithKline (GSK) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 28.1 | 13.7 | 27.5 | 38.1 | 37.5 | 21.5 | |||
| Changes by years, y/y, % | +60% | -51% | +100% | +38% | -1% | +27.0% | |||
GlaxoSmithKline. P/FCF
GlaxoSmithKline. P/FCF, changes, %
GlaxoSmithKline (GSK) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| P/FCF | 63.1 | 46.4 | 36.3 | 35.8 | 34.5 | 21.5 | ||
| Changes by years, y/y, % | +578% | +704% | +32% | +30% | -35% | |||
| Changes by quarters, q/q, % | -46% | -26% | -22% | -1% | -4% | |||
